Relevance of transgenic mouse models for Alzheimer's disease
Authors:
- 1 January 2021
- book chapter
- Published by Elsevier
- Vol. 177, 1-48
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- N-truncated amyloid β (Aβ) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficitsActa Neuropathologica, 2013
- Mouse models of Alzheimer's diseaseBrain Research Bulletin, 2012
- Pyroglutamate Amyloid β (Aβ) Aggravates Behavioral Deficits in Transgenic Amyloid Mouse Model for Alzheimer DiseaseJournal of Biological Chemistry, 2012
- Abnormal Cognition, Sleep, EEG and Brain Metabolism in a Novel Knock-In Alzheimer Mouse, PLB1PLOS ONE, 2011
- Pathogenic Forms of Tau Inhibit Kinesin-Dependent Axonal Transport through a Mechanism Involving Activation of Axonal PhosphotransferasesThe Journal of Neuroscience, 2011
- Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathologyEMBO Reports, 2006
- The Arctic Alzheimer mutation facilitates early intraneuronal Aβ aggregation and senile plaque formation in transgenic miceNeurobiology of Aging, 2006
- Persistent Amyloidosis following Suppression of Aβ Production in a Transgenic Model of Alzheimer DiseasePLOS Medicine, 2005
- Role of presenilin-1 in cortical lamination and survival of Cajal-Retzius neuronsDevelopmental Biology, 2005
- A vector for expressing foreign genes in the brains and hearts of transgenic miceGenetic Analysis: Biomolecular Engineering, 1996